Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.

× No keyword cloud information.

19 in total

Review 1. Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.

Authors: Andre Arizpe; Kelly R Reveles; Shrina D Patel; Samuel L Aitken
Journal: Curr Infect Dis Rep Date: 2016-12 Impact factor: 3.725

2. Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections.

Authors: Laura Escolà-Vergé; Carles Pigrau; Ibai Los-Arcos; Ángel Arévalo; Belen Viñado; David Campany; Nieves Larrosa; Xavier Nuvials; Ricard Ferrer; Oscar Len; Benito Almirante
Journal: Infection Date: 2018-03-28 Impact factor: 3.553

3. Molecular Characterization of Baseline Enterobacterales and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial.

Authors: Mariana Castanheira; Matthew G Johnson; Brian Yu; Jennifer A Huntington; Patricia Carmelitano; Christopher Bruno; Elizabeth G Rhee; Mary Motyl
Journal: Antimicrob Agents Chemother Date: 2021-02-17 Impact factor: 5.191

Review 4. Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon?

Authors: Lynn Nguyen; Joshua Garcia; Katherine Gruenberg; Conan MacDougall
Journal: Curr Infect Dis Rep Date: 2018-06-06 Impact factor: 3.725

5. Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.

Authors: Jose M Munita; Samuel L Aitken; William R Miller; Federico Perez; Rossana Rosa; Luis A Shimose; Paola N Lichtenberger; Lilian M Abbo; Rupali Jain; Masayuki Nigo; Audrey Wanger; Rafael Araos; Truc T Tran; Javier Adachi; Robert Rakita; Samuel Shelburne; Robert A Bonomo; Cesar A Arias
Journal: Clin Infect Dis Date: 2017-07-01 Impact factor: 9.079

6. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.

Authors: Alberto Hernández-Tejedor; Carmen Débora Merino-Vega; Alfredo Martín-Vivas; Rafael Ruiz de Luna-González; Alberto Delgado-Iribarren; Ángeles Gabán-Díez; Ignacio Temprano-Gómez; Natalia de la Calle-Pedrosa; Ana Isabel González-Jiménez; Alejandro Algora-Weber
Journal: Infection Date: 2016-09-26 Impact factor: 3.553

7. Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.

Authors: Seetha M Tamma; Alice J Hsu; Pranita D Tamma
Journal: Paediatr Drugs Date: 2016-02 Impact factor: 3.022

8. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

Authors: Ghady Haidar; Nathan J Philips; Ryan K Shields; Daniel Snyder; Shaoji Cheng; Brian A Potoski; Yohei Doi; Binghua Hao; Ellen G Press; Vaughn S Cooper; Cornelius J Clancy; M Hong Nguyen
Journal: Clin Infect Dis Date: 2017-07-01 Impact factor: 9.079

Review 9. Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections.

Authors: Laura Puzniak; Ryan Dillon; Thomas Palmer; Hannah Collings; Ashley Enstone
Journal: Infect Dis Ther Date: 2021-07-18

Review 10. Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.

Authors: Luca Gregorio Giaccari; Maria Caterina Pace; Maria Beatrice Passavanti; Francesca Gargano; Caterina Aurilio; Pasquale Sansone
Journal: Life (Basel) Date: 2021-05-24